There were two hepatoma cell lines, Huh7.5 and HLCZ01, that were used for investigating the mechanisms of IL-28A and EPSTI1 to inhibit HCV propagation in our study. This evidence concerns the gene IFNL2 and hepatocellular carcinoma.